Drugs / F2695 SR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01034267 | Dec 2009 → Jun 2012 | major depressive disorder | Forest Laboratories | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F2695 SR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01034267 ↗ |
| Route | Oral | “to be given orally in capsule form once daily” NCT01034267 ↗ |